Related Experiment Video
Updated: Jun 29, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
The control of dendritic cell maturation by pH-sensitive polyion complex micelles
Ariane Boudier1, Anne Aubert-Pouëssel, Pascale Louis-Plence
1Institut Charles Gerhardt Montpellier, UMR 5253 CNRS/ENSCM/UM2/UM1, 8 rue de l'Ecole Normale, F-34296 Montpellier Cedex 5, France.
Biomaterials
|October 15, 2008
Summary
New block copolymer micelles efficiently deliver therapeutic molecules into dendritic cells for cancer vaccines and autoimmune disease treatments. These engineered immune cells offer enhanced therapeutic potential.
Area of Science:
- Biomaterials Science
- Immunology
- Nanotechnology
Background:
- Dendritic cell (DC) engineering is crucial for advanced immunotherapies.
- Efficient delivery of therapeutic molecules into DCs remains a challenge.
Purpose of the Study:
- To design and optimize double-hydrophilic block copolymer micelles as vectors for ex vivo DC engineering.
- To evaluate micelle characteristics, stability, cellular uptake, and biocompatibility.
Main Methods:
- Synthesis and characterization of polymethacrylic acid-b-polyethylene oxide (PMAA-b-POE)/poly-L-lysine micelles.
- Assessment of micelle size, stability under physiological and acidic conditions.
- Evaluation of micelle endocytosis in bone marrow-derived dendritic cells using flow cytometry and microscopy.
Main Results:
- Optimized micelles exhibited a 30 nm hydrodynamic diameter with a unique core structure.
- Micelles demonstrated high stability in physiological conditions and disassembly in acidic environments.
- Efficient endocytosis by dendritic cells was confirmed, along with excellent biocompatibility.
Conclusions:
- The developed micelles are effective vectors for ex vivo dendritic cell engineering.
- These micelles facilitate controlled dendritic cell maturation, enhancing their therapeutic applications.
- This platform holds promise for developing novel cancer vaccines and immunotherapies for autoimmune diseases.
